GPT and metabolic dysfunction-associated steatotic liver disease: These investigations reveal a consistent association between this genetic polymorphism and elevated alanine transaminase (ALT) levels, an increased risk of liver diseases such as non-alcoholic fatty liver disease (NAFLD).